Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease

Journal of Neurology

Volumn 258, Issue 12, 2011, Pages 2296-2299

  Tambasco, Nicola ^a   Belcastro, Vincenzo ^b   Gallina, Antongiulio ^a   Castrioto, Anna ^a   Calabresi, Paolo ^a,c   Rossi, Aroldo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SANT ANNA HOSPITAL   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

AGED; AGITATION; BEHAVIOR CHANGE; BRADYKINESIA; BREATHING DISORDER; CASE REPORT; CONFUSION; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG RECHALLENGE; HUMAN; KIDNEY FAILURE; LETTER; LEUKOENCEPHALOPATHY; MALE; MOTOR PERFORMANCE; MULTICHANNEL RECORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RIGIDITY; SIDE EFFECT;

AGED; ANTIPARKINSON AGENTS; CARBIDOPA; COGNITION DISORDERS; DRUG COMBINATIONS; HUMANS; LEVODOPA; MALE; MENTAL DISORDERS; PARKINSON DISEASE; RESPIRATION DISORDERS;

EID: 83255191710     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6119-5     Document Type: Letter

References (8)

1. Pal PK, Sathyaprabha TN, Tuhina P, Thennarasu K (2007) Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa. Mov Disord 22(3):420-424 (Pubitemid 46569704)
2. Mehanna R, Jankovic J (2010) Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord 16:628-638
3. Rice JE, Antic R, Thompson PD (2002) Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease. Mov Disord 17(3):524-527 (Pubitemid 36040966)
4. Jankovic J, Nour F (1986) Respiratory dyskinesia in Parkinson's disease. Neurology 36:303-304
5. De Keyser J, Vincken W (1985) L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride. Neurology 35(2):235-237 (Pubitemid 15171523)
6. Weiner WJ, Goetz CG, Nausieda PA, Klawans HL (1978) Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med 88(3):327-331 (Pubitemid 8287464)
7. Farid K, Sibon I, Guehl D, Cuny E, Burbaud P, Allard M (2009) Brain dopaminergic modulation associated with executive function in Parkinson's disease. Mov Disord 24(13):1962-1969
8. Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11:1136-1143 (Pubitemid 33108240)